118 results
Page 4 of 6
S-3ASR
wim773yy278s1k35
8 Apr 21
Automatic shelf registration
4:11pm
8-K
EX-99.1
4kqik21gl11l1wx
2 Mar 21
Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
7:05am
8-K
EX-99.2
ylw02ui2ha7 t5
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-10.1
lunht jmh2wuivgx3j
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-99.1
pitf0600e3c770
29 Jan 21
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
7:03am
8-K
EX-99.1
cqxlsxf
19 Jan 21
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
7:03am
8-K
EX-99.1
v6am74z
14 Jan 21
Interactions with FDA anticipated by mid-2021 to determine the BLA filing strategy for OTL-200
7:03am
8-K
EX-99.1
f3xahbyl5w p8e6g
11 Jan 21
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
0i1iclyj
21 Dec 20
First gene therapy to receiveĀ full EU marketing authorization for eligible MLD patients
7:03am
8-K
EX-99.1
1azzrkp7wb gr
19 Nov 20
Other Events
7:03am
8-K
EX-99.1
cyc9hlza7er
3 Nov 20
Orchard Therapeutics Reviews Recent Portfolio Progress and Reports Third Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
x4st19jmfi3w31s8y
16 Oct 20
Other Events
6:03am
S-8
EX-5.1
a8ihwkkylmm5kpn99q9
6 Aug 20
Registration of securities for employees
4:07pm
10-Q
6ku28asllqy 6q
7 May 20
Quarterly report
4:03pm
8-K
EX-10.2
wwm0wljrnq5gpeoo2u
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
POSASR
EX-5.3
rdn 6sativ
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am